Unknown

Dataset Information

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.


ABSTRACT:

Introduction

We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer. This analysis, followed by functional characterization, resulted in the identification of Jumonji Domain Containing 6 (JMJD6) protein as a novel driver of oncogenic properties in breast cancer.

Methods

Through microarray informatics, Cox proportional hazards regression was used to analyze the correlation between gene expression and distant metastasis-free survival (DMFS) of patients in 14 independent breast cancer cohorts. JMJD6 emerged as a top candidate gene robustly associated with poor patient survival. Immunohistochemistry, siRNA-mediated silencing, and forced overexpression of JMJD6 in cell-bas

SUBMITTER: Lee YF 

PROVIDER: S-EPMC3446348 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature